Guatemala’s Ministry of Public Health and Social Assistance (MSPAS) officially added the chickenpox vaccine to its National Immunization Program on november 11, 2025. This move represents a critically important advancement ⁤in preventative⁣ healthcare for‍ the country, aiming to⁢ reduce the incidence of severe chickenpox cases and alleviate strain on the healthcare⁣ system.

The introduction follows⁤ a complete preparation process, including a ‍thorough burden analysis, a review of international evidence, strengthening of ⁣the cold chain infrastructure, ⁢training of health personnel, and updates to ‌facts systems. Minister of ⁢Health ​Dr. Joaquín Barnoya Pérez affirmed the country’s readiness to ensure a safe, efficient, and sustained⁣ vaccine rollout.

Modernizing Immunization Efforts

Dr. Barnoya Pérez highlighted⁤ that the inclusion of the ⁤chickenpox vaccine builds upon recent progress made‌ with ‌the hexavalent ⁤vaccine, ‌marking ​a continued modernization⁤ of Guatemala’s ⁢National Immunization Program.​ The vaccine was procured through ⁣the Pan American Health Institution⁢ (PAHO) Revolving ‍Fund, a mechanism that guarantees access to quality vaccines at competitive prices and ensures long-term sustainability. PAHO’s‍ Revolving Fund has⁢ been ⁢instrumental in helping countries across⁢ the ​Americas secure affordable vaccines.

Officials‌ anticipate that this strategy will considerably ​reduce​ complications associated with chickenpox, thereby lowering healthcare costs for families and easing the burden on⁤ hospitals.

Expected​ Benefits⁢ and Impact

The ⁢introduction of​ the chickenpox⁢ vaccine is expected ‍to have a considerable⁤ and lasting impact ⁢on public health‌ in Guatemala. Key benefits include:

• A sustained reduction in ⁢severe chickenpox cases.
• Reduced congestion in pediatric services.
• Optimized allocation of hospital resources.
• Increased public confidence‍ in preventative ⁤healthcare ​measures.

The benefits are projected to be both immediate and cumulative, contributing to a more resilient and equitable healthcare system.

Key Personnel involved

The historic event was attended by several key figures in Guatemalan healthcare:

• Dr. Joaquín Barnoya Pérez, Minister‌ of Public Health and Social ⁤Assistance
• Dr. ‍Edgar Rolando González, Vice Minister of Health‌ Regulation,⁣ Surveillance and Control
• Dr. Miriam Johanna Canet Elgueta, ‌Director‍ of Regulations ⁣for Human Care Programs
• Master Sandy Sorayda Cano⁤ lemus, Coordinator of the National Immunization Program
• Evelyn Sicán, Delegate ⁢of the National Council of ⁢Immunization Practices (CONAPI)
• Dr. Alma Morales‌ Salinas, PAHO/WHO Representative in Guatemala, along ​with the​ PAHO/WHO immunization technical team.